Research Progress of BTK Inhibitors in the Treatment of Inflammatory and Autoimmune Diseases
-
Published:2022
Issue:01
Volume:10
Page:70-83
-
ISSN:2331-8287
-
Container-title:Hans Journal of Medicinal Chemistry
-
language:
-
Short-container-title:HJMCe
Publisher
Hans Publishers
Reference39 articles.
1. X-linked agammaglobulinemia: lack of mature B lineage cells caused by mutations in the Btk kinase
2. Bruton’s tyrosine kinase (Btk): function, regulation, and transformation with special emphasis on the PH domain
3. Fasano, S. and Isenberg, D.A. (2019) Present and Novel Biologic Drugs in Primary Sjögren’s Syndrome. Clinical and Experimental Rheumatology, 37, S167-S174.
4. Kinnunen, T., Chamberlain, N., Morbach, H., et al. (2013) Specific Peripheral B Cell Tolerance De-fects in Patients with Multiple Sclerosis. Journal of Clinical Investigation, 123, 2737-2741.
5. Specific Btk inhibition suppresses B cell– and myeloid cell–mediated arthritis
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献